Lobbying

Ambulatory Surgery Center Association's latest lobbying report covers Q2 2026, at $120K. The four quarters Q3 2025–Q2 2026 total $480K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Health Issues.

Ambulatory Surgery Center Association

Latest quarter
$120K
Q2 2026 · 2 reports
Last 12 months
$480K
Last 4 quarters
vs last quarter
0.0%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Ambulatory Surgery Center Association lobbying by quarter
Ambulatory Surgery Center Association lobbying by quarter
QuarterAmountReports
Q4 2022$165K2
Q1 2023$165K2
Q2 2023$165K2
Q3 2023$165K2
Q4 2023$165K2
Q1 2024$165K2
Q2 2024$165K2
Q3 2024$165K2
Q4 2024$165K2
Q1 2025$120K2
Q2 2025$120K2
Q3 2025$120K2
Q4 2025$120K2
Q1 2026$120K2
Q2 2026$120K2

Policy issues the reports name

  • Medicare and Medicaid30 reports
  • Health issues23 reports
  • Veterans2 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES30 reports
  • SENATE30 reports
  • Centers For Medicare and Medicaid Services (CMS)18 reports
  • Health & Human Services, Dept of (HHS)15 reports

Firms it paid

Firm
In-houseAmbulatory Surgery Center Association$1.3M15 quarters
The McManus Group$900K15 quarters

Former officials lobbying for it

Former position
JOHN MCMANUSStaff Director W&M Health Subcommittee; LA, Rep. Bill ThomasQ2 2026
ALANNA TEMMELD, Rep. Jon Porter.Q4 2023

Lobbying reports

Filed by
07/20for Q2The McManus Group$60K
07/20for Q2In-house$60K
04/20for Q1The McManus Group$60K
04/17for Q1In-house$60K
01/20for Q4 2025The McManus Group$60K
01/20for Q4 2025In-house$60K
25/10/20for Q3 2025The McManus Group$60K
25/10/20for Q3 2025In-house$60K
25/07/21for Q2 2025The McManus Group$60K
25/06/17for Q2 2025In-house$60K
25/04/23for Q1 2025In-house$60K
25/04/21for Q1 2025The McManus Group$60K
25/01/27for Q4 2024In-house$105K
25/01/21for Q4 2024The McManus Group$60K
24/10/21for Q3 2024The McManus Group$60K
24/10/17for Q3 2024In-house$105K
24/07/17for Q2 2024In-house$105K
24/07/16for Q2 2024The McManus Group$60K
24/04/23for Q1 2024In-house$105K
24/04/22for Q1 2024The McManus Group$60K